[Topical interferon alpha 2 beta therapy in the management of conjunctival intraepithelial neoplasia].
Albornoz López
R
R
Fernández García
M I
MI
Pérez Rodrigo
I
I
D000287:Administration, Topical; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000150:complications / Q000188:drug therapy*; D003230:Conjunctival Neoplasms / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins